US · YDES
YD Bio Limited Ordinary Shares
- Sector
- Healthcare · Biotechnology
- Headquarters
- Taipei 115001
- Website
- ydesgroup.com
Price · as of 2026-07-06
$2.34
Market cap 216.39M
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $0.00 | $0.00 | |||
| 2025 | $0.00 | $0.00 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| YDES | YD Bio Limited Ordinary S… | $1.90 | 216.39M | — | — | — | — | — | — | — | — | — |
| BTX | BlackRock Technology and … | $9.16 | 1.07B | +144% | — | — | — | 35.90 | 0.72 | 31.50 | — | -8113.00% |
| DAWN | Day One Biopharmaceutical… | $21.53 | 2.22B | +31% | +25,965% | — | — | -9.99 | 2.43 | 6.78 | -5.99 | 2060.00% |
| GERN | Geron Corporation | $1.25 | 801.9M | — | — | — | — | — | — | — | — | — |
| GLUE | Monte Rosa Therapeutics, … | $19.39 | 1.26B | — | — | -98% | — | — | — | — | — | — |
| LENZ | LENZ Therapeutics, Inc. | $7.99 | 250.52M | — | — | — | — | — | — | — | — | — |
| MRVI | Maravai LifeSciences Hold… | $4.64 | 673.24M | +1,829% | -58% | — | +270% | -2.27 | 2.47 | 2.82 | -4.45 | -2834.00% |
| PRME | Prime Medicine, Inc. | $3.40 | 614.1M | — | — | — | — | — | — | — | — | — |
| TBPH | Theravance Biopharma, Inc… | $16.21 | 835.67M | — | — | +1% | +838% | — | — | — | — | — |
| TYRA | Tyra Biosciences, Inc. | $32.68 | 1.94B | — | — | — | — | -7.24 | 1.82 | — | -2.80 | — |
| VIR | Vir Biotechnology, Inc. | $9.55 | 1.61B | +132% | -53% | — | — | -2.95 | 1.69 | 18.87 | -2.39 | -761.00% |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $2.34) − 1 = — (DCF, example).